Sulphonamides vs tetracycline
Other adverse events ‐ not reported · patients with Shigella dysentery
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Findings
What do systematic reviews say?
2,016 questions · 2,067 findings · 222 reviews · Headline outcomes only
No studies found 471 · 22.8%GRADE not reported 108 · 5.2%Very low 570 · 27.6%Low 458 · 22.2%Moderate 363 · 17.6%High 97 · 4.7%
Fluoroquinolones vs beta‐lactams
Diarrhoea · patients with Shigella dysentery
It is very uncertain whether fluoroquinolones changes diarrhoea on compared with beta‐lactams (very low certainty).
1 finding from 1 review
- RR 1.03 [0.45, 2.37]6 studies · 686 participantsVery low
Fluoroquinolones vs beta‐lactams
Relapse · patients with Shigella dysentery
It is very uncertain whether fluoroquinolones changes relapse ‐ All trials clinical criteria compared with beta‐lactams (very low certainty).
1 finding from 1 review
- RR 0.91 [0.11, 7.55]3 studies · 357 participantsVery low
Fluoroquinolones vs beta‐lactams
Serious adverse events clinical criteria · patients with Shigella dysentery
It is very uncertain whether fluoroquinolones changes serious adverse events clinical criteria compared with beta‐lactams (very low certainty).
1 finding from 1 review
- RR 10.9 [0.61, 194.82]1 study · 221 participantsVery low
Fluoroquinolones vs beta‐lactams
Discontinuation of medication due to adverse events · patients with Shigella dysentery
It is very uncertain whether fluoroquinolones changes adverse events leading to discontinuation of treatment compared with beta‐lactams (very low certainty).
1 finding from 1 review
- RR 1.02 [0.27, 3.89]1 study · 127 participantsVery low
Intervention not reported
Spontaneous bacterial peritonitis · Cirrhotic patients with ascites, without gastro‐intestinal bleeding and no current spontaneous bacterial peritonitis
It is very uncertain whether the intervention changes spontaneous bacterial peritonitis (very low certainty).
1 finding from 1 review
- Antibiotic prophylaxis for spontaneous bacterial peritonitis in cirrhotic patients with ascites, without… 2009 · Cochrane Headline outcomes onlyRR 0.2 [0.11, 0.37]7 studies · 538 participantsVery low
Intervention not reported
Mortality · Cirrhotic patients with ascites, without gastro‐intestinal bleeding and no current spontaneous bacterial peritonitis
It is very uncertain whether the intervention changes mortality (very low certainty).
1 finding from 1 review
- Antibiotic prophylaxis for spontaneous bacterial peritonitis in cirrhotic patients with ascites, without… 2009 · Cochrane Headline outcomes onlyRR 0.61 [0.43, 0.87]7 studies · 538 participantsVery low
Third generation cephalosporins vs conventional therapy
Death · patients treated for acute bacterial meningitis
1 finding from 1 review
- Third generation cephalosporins versus conventional antibiotics for treating acute bacterial meningitis 2007 · Cochrane Headline outcomes onlyno estimate extracted19 studies · 1496 participantsGRADE not reported
Third generation cephalosporins vs conventional therapy
Death · patients treated for meningococcal meningitis
1 finding from 1 review
- Third generation cephalosporins versus conventional antibiotics for treating acute bacterial meningitis 2007 · Cochrane Headline outcomes onlyno estimate extracted13 studies · 477 participantsGRADE not reported
Third generation cephalosporins vs conventional therapy
Deafness · patients treated for acute bacterial meningitis
1 finding from 1 review
- Third generation cephalosporins versus conventional antibiotics for treating acute bacterial meningitis 2007 · Cochrane Headline outcomes onlyno estimate extracted10 studies · 501 participantsGRADE not reported
Third generation cephalosporins vs conventional therapy
Culture positivity 10 to 48 hours start of treatment · patients treated for acute bacterial meningitis
1 finding from 1 review
- Third generation cephalosporins versus conventional antibiotics for treating acute bacterial meningitis 2007 · Cochrane Headline outcomes onlyno estimate extracted12 studies · 442 participantsGRADE not reported
Third generation cephalosporins vs conventional therapy
Diarrhoea · patients treated for acute bacterial meningitis
1 finding from 1 review
- Third generation cephalosporins versus conventional antibiotics for treating acute bacterial meningitis 2007 · Cochrane Headline outcomes onlyno estimate extracted12 studies · 750 participantsGRADE not reported
Third generation cephalosporins vs conventional therapy
Neutropenia · patients treated for acute bacterial meningitis
1 finding from 1 review
- Third generation cephalosporins versus conventional antibiotics for treating acute bacterial meningitis 2007 · Cochrane Headline outcomes onlyno estimate extracted10 studies · 472 participantsGRADE not reported
Third generation cephalosporins vs conventional therapy
Rash · patients treated for acute bacterial meningitis
1 finding from 1 review
- Third generation cephalosporins versus conventional antibiotics for treating acute bacterial meningitis 2007 · Cochrane Headline outcomes onlyno estimate extracted8 studies · 533 participantsGRADE not reported
Third generation cephalosporins vs conventional therapy
Treatment failure (either death or deafness) · patients treated for acute bacterial meningitis
1 finding from 1 review
- Third generation cephalosporins versus conventional antibiotics for treating acute bacterial meningitis 2007 · Cochrane Headline outcomes onlyno estimate extracted19 studies · 1496 participantsGRADE not reported
Cephalosporins vs conventional therapy
Death · patients treated for H. influenzae meningitis
1 finding from 1 review
- Third generation cephalosporins versus conventional antibiotics for treating acute bacterial meningitis 2007 · Cochrane Headline outcomes onlyno estimate extracted10 studies · 318 participantsGRADE not reported